Literature DB >> 22515122

Establishment and optimal culture conditions of microrna-induced pluripotent stem cells generated from HEK293 cells via transfection of microrna-302s expression vector.

Naoshi Koide1, Kaori Yasuda, Kenji Kadomatsu, Yoshifumi Takei.   

Abstract

Induced pluripotent stem cells (iPSCs) have been directly generated from fibroblast cultures though retrovirus- or lentivirus-mediated ectopic overexpression of only a few defined transcriptional factors. This remarkable achievement has greatly enhanced our ability to explore the causes of, and potential cures for, many genetic diseases, and strengthened the promise of regenerative medicine. In fact, to date, many kinds of somatic cells from different tissues have exhibited a capacity for reprogramming toward an embryonic stem cell-like state, but major bottlenecks in iPSC derivation and therapeutic use remain, including low reprogramming efficiencies and the tumorigenesis of the generated iPSC. Here, we successfully generated miR-302s-induced pluripotent stem cells (mirPS cells) from human embryonic kidney (HEK) 293 cells via transfection of the miR-302s expression vector. We also determined the optimal culture conditions to generate mirPS on feeder cells, which included the use of serum-free N2B27 medium. The mirPS cells generated by our improved conditions showed the expression of pluripotent marker genes such as OCT3/4, NANOG, and SOX2 under growth conditions via reverse transcription-PCR, whereas no expression of these genes was observed in HEK293 cells. On the other hand, under differentiation conditions, mirPS cells formed ball-shaped structures (embryoid bodies), and showed the ability to differentiate into three germ layers (ectoderm, mesoderm, and endoderm) in vitro. The results suggested that our generated mirPS cells are actually functional as a cell resource to apply to regenerative medicine, and mirPS cells are suitable materials to clarify the mechanism underlying the reprogramming from somatic cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515122      PMCID: PMC4831261     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  26 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 2.  Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells.

Authors:  Bo Feng; Jia-Hui Ng; Jian-Chien Dominic Heng; Huck-Hui Ng
Journal:  Cell Stem Cell       Date:  2009-04-03       Impact factor: 24.633

3.  Comparative study of mouse and human feeder cells for human embryonic stem cells.

Authors:  Livia Eiselleova; Iveta Peterkova; Jakub Neradil; Iva Slaninova; Ales Hampl; Petr Dvorak
Journal:  Int J Dev Biol       Date:  2008       Impact factor: 2.203

4.  Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

Authors:  Norikatsu Miyoshi; Hideshi Ishii; Hiroaki Nagano; Naotsugu Haraguchi; Dyah Laksmi Dewi; Yoshihiro Kano; Shinpei Nishikawa; Masahiro Tanemura; Koshi Mimori; Fumiaki Tanaka; Toshiyuki Saito; Junichi Nishimura; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Hirofumi Yamamoto; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Journal:  Cell Stem Cell       Date:  2011-06-03       Impact factor: 24.633

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  Senescence impairs successful reprogramming to pluripotent stem cells.

Authors:  Ana Banito; Sheikh T Rashid; Juan Carlos Acosta; SiDe Li; Carlos F Pereira; Imbisaat Geti; Sandra Pinho; Jose C Silva; Veronique Azuara; Martin Walsh; Ludovic Vallier; Jesús Gil
Journal:  Genes Dev       Date:  2009-08-20       Impact factor: 11.361

7.  Embryonic stem cell-specific microRNAs promote induced pluripotency.

Authors:  Robert L Judson; Joshua E Babiarz; Monica Venere; Robert Blelloch
Journal:  Nat Biotechnol       Date:  2009-04-12       Impact factor: 54.908

8.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

9.  Regulation of somatic cell reprogramming through inducible mir-302 expression.

Authors:  Shi-Lung Lin; Donald C Chang; Chun-Hung Lin; Shao-Yao Ying; Davey Leu; David T S Wu
Journal:  Nucleic Acids Res       Date:  2010-09-24       Impact factor: 16.971

10.  Induced pluripotent stem (iPS) cells: an up-to-the-minute review.

Authors:  Frank Lau; Tim Ahfeldt; Kenji Osafune; Hidenori Akustsu; Chad A Cowan
Journal:  F1000 Biol Rep       Date:  2009-11-16
View more
  4 in total

1.  Characterization of embryonic stem-like cells derived from HEK293T cells through miR302/367 expression and their potentiality to differentiate into germ-like cells.

Authors:  Long Wang; Haijing Zhu; Jiang Wu; Na Li; Jinlian Hua
Journal:  Cytotechnology       Date:  2013-10-05       Impact factor: 2.058

Review 2.  microRNA control of mouse and human pluripotent stem cell behavior.

Authors:  Tobias S Greve; Robert L Judson; Robert Blelloch
Journal:  Annu Rev Cell Dev Biol       Date:  2013-07-12       Impact factor: 13.827

3.  Classical non-homologous end-joining pathway utilizes nascent RNA for error-free double-strand break repair of transcribed genes.

Authors:  Anirban Chakraborty; Nisha Tapryal; Tatiana Venkova; Nobuo Horikoshi; Raj K Pandita; Altaf H Sarker; Partha S Sarkar; Tej K Pandita; Tapas K Hazra
Journal:  Nat Commun       Date:  2016-10-05       Impact factor: 14.919

4.  An Alternate Approach to Generate Induced Pluripotent Stem Cells with Precise CRISPR/Cas9 Tool.

Authors:  Nasir Javaid; Sangdun Choi
Journal:  Stem Cells Int       Date:  2022-09-22       Impact factor: 5.131

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.